Efficiency of Akkermansia muciniphila in type 2 diabetes and obesity

Journal Title: Journal of Current Biomedical Reports - Year 2020, Vol 1, Issue 1

Abstract

Akkermansia muciniphila is an anaerobic species of gut microbiome that has been proposed as a new functional microbiota with probiotic properties. Recent research has shown the amazing abilities of probiotic bacteria, A. muciniphila, which resides in most people's intestines. These bacteria affect the body if it increases or decreases abdominal fat. The presence of A. muciniphila has opened new ways for the use of this plentiful intestinal symbiont in next-generation therapeutic products, as well as targeting microbiota dynamics. A. muciniphila is particularly effective in increasing mucosal thickness and enhancing bowel barrier function. As a result, host metabolic markers improve. The host functions that are disrupted in various diseases with a particular focus on metabolic disorders in animals and humans. A specific protein in the outer membrane of A. muciniphila called Amuc-110 could in the future be a strong candidate for drug production. As a result, we suggest that microbes and our microbiology or gut microbiome knowledge could be a new source for future treatments. The objectives of this review are to summarize the data available on the distribution of A. muciniphila gut in health and disease, to provide insights into the environment and its role in the creation of microbial networks at the mucosal interface, as well as to discuss recent research on its role in regulation.

Authors and Affiliations

Farzaneh Mohammadzadeh Rostami, Saman Shalibeik, Bahram Nasr Esfahani

Keywords

Related Articles

Detecting of biofilm formation in the clinical isolates of Pseudomonas aeruginosa and Escherichia coli: an evaluation of different screening methods

Biofilm producer bacteria cause nosocomial, chronic, and recurrent human infections. It is hard to treat biofilm-embedded bacteria because they are more resistant to antimicrobials than planktonic bacteria. The present s...

Using decoction of some vitamin C enriched plants for the management of COVID-19 in Jos, Nigeria: A case report

The worldwide influence of coronavirus disease 2019 (COVID-19) pandemic compelled the global health organizations to prioritize the situation over all other related community health issues. The lack of specific treatment...

Molecular investigation of extended-spectrum β-lactamases (ESBLs) genes in the Salmonella isolates obtained from children with acute diarrhea

Salmonellosis is an important public health concern among children in worldwide. Extended-spectrum β-lactams (ESBLs) cause resistance to clinically important beta-lactams which are generally used to treat invasive Salmon...

Decrease of microbial contamination by application of routinely glycerol and phenol solution on human cadavers

Human cadaver is imperative learning material for medical students. The cadavers expose to microbial contamination every time anatomists work with them. The microorganisms found in preparations’ cadavers could be pathoge...

Investigating the effect of ghrelin on improving memory and learning ability in animals: A systematic review

Ghrelin does an important role in neurological functions such as memory, learning, and cognition as well. There is some evidence that ghrelin can improve memory. This study aimed to evaluate the effects of ghrelin on rat...

Download PDF file
  • EP ID EP688953
  • DOI -
  • Views 293
  • Downloads 0

How To Cite

Farzaneh Mohammadzadeh Rostami, Saman Shalibeik, Bahram Nasr Esfahani (2020). Efficiency of Akkermansia muciniphila in type 2 diabetes and obesity. Journal of Current Biomedical Reports, 1(1), -. https://www.europub.co.uk/articles/-A-688953